Showing results (1441-1450 of 5,146) with videos related to

Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|January 24, 2026
Real-world effectiveness and safety of ofatumumab in relapsing multiple sclerosis: A multicenter cohort studyKatarina Tešija, Magdalena Krbot Skorić, Vanja Bašić Kes, et al.
Multiple Sclerosis and Related Disorders|February 8, 2026
Reduced retinal neuronal injury as a consequence of high efficacy DMT treatment: an OCT studyAntonio Francesco Vacca, Su-Chun Huang, Elisa Idini, et al.
Multiple Sclerosis and Related Disorders|January 25, 2026
Multiple sclerosis and related disorders multiple sclerosis across Isfahan Province, Iran: Urban-rural disparities and no association with air quality measuresMasoud Etemadifar, Shakila Bagheri, Ahmadreza Dehghani, et al.
Multiple Sclerosis and Related Disorders|January 26, 2026
Post-infusion observation of patients with multiple sclerosis receiving natalizumab: Is it necessary?Melika Arab Bafrani, Negar Sadat Ahmadi, Fateme Zahra Idjadi, et al.
Multiple Sclerosis and Related Disorders|March 27, 2025
First insights into the safety and effectiveness of additional courses with cladribine tablets under real-world conditionsChristoph Kleinschnitz, Jelena Skuljec, Markus C Kowarik, et al.
Multiple Sclerosis and Related Disorders|March 18, 2025
Reliability and validity of the novel-lower extremity dexterity assessment in people with multiple sclerosisNuman Yavuz, Fatih Soke, Fatma Kurtulus Aydin, et al.
Multiple Sclerosis and Related Disorders|November 21, 2017
Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patientsEdgar Carnero Contentti, Vanessa Daccach Marques, Ibis Soto de Castillo, et al.
Multiple Sclerosis and Related Disorders|November 7, 2017
Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosisYaqing Shu, Rui Li, Wei Qiu, et al.
Pageof 515